help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rendl, J.
Right arrow Articles by Reiners, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rendl, J.
Right arrow Articles by Reiners, C.
The Journal of Clinical Endocrinology & Metabolism Vol. 83, No. 3 1007-1012
Copyright © 1998 by The Endocrine Society


Original Studies

Rapid Urinary Iodide Test

J. Rendl, D. Bier, T. Groh and C. Reiners

Clinic of Nuclear Medicine (J.R., D.B., C.R.), University of Würzburg, D-97080 Würzburg, Germany; and Merck KGaA (T.G.), D-64271 Darmstadt, Germany

Address all correspondence and requests for reprints to: Dr. Johann Rendl, Clinic of Nuclear Medicine, University of Wuerzburg, Josef-Schneider-Straße 2, D-97080 Wuerzburg, Germany. E-mail: rendl{at}nuklearmedizin.uni-wuerzburg.de


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Assessment of iodine deficiency and monitoring of iodine supplementation programs demand rapid, simple, and cost-effective methods for the determination of urinary iodide concentrations. We propose a semiquantitative rapid test, based on the iodide-catalyzed oxidation of 3,3',5,5'-tetramethylbenzidine by peracetic acid/H2O2, to yield colored products. The color of the chemical reaction is compared with color categories of a pictogram corresponding to three ranges: <100, 100–300, and >300 µg/L (<0.79, 0.79–2.36, and >2.36 µmol/L) of iodide concentrations. The test is very easy to perform and does not require any instrumentation or apparatus. Sample preparation is simple and consists of the removal of interfering substances by disposable columns, 65 x 10.5 mm, packed with purified activated charcoal. For comparison with a reference method for measuring urinary iodide, by high-performance liquid chromatography, we determined the iodide concentrations of 370 random (untimed) urine samples from consecutive patients by both high-performance liquid chromatography and the rapid test. The results obtained by both methods are in close agreement, with respect to classification of the samples according to the above three ranges, with a maximum difference of less than 5% for each range. Median (y) values of a given distribution of urinary iodide concentrations can be calculated from the percent (x) of samples below 100 µg/L (0.79 µmol/L) using the regression equation: y = 179.78 - 1.60x. This rapid test, therefore, is suited to epidemiological surveys of iodine deficiency, especially in developing countries.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
IODINE deficiency is a major health problem worldwide, with about 1600 million people (mostly in developing countries) being currently at risk of iodine deficiency disorders (IDD) (1, 2, 3, 4). Effective control of iodine deficiency by iodine supplementation is still a challenge, especially in developing countries (5). Because most iodide is excreted in the urine, urinary iodide excretion is currently the most convenient laboratory marker of iodine deficiency (6). The present recommendation (7) is to evaluate the iodine intake of a given population by the measurements of iodide concentrations in a representative number (at least 50–100) of casual urine samples collected within the population (8). Automated equipment [e.g. Technicon Autoanalyzer (9, 10) or high-performance liquid chromatography (HPLC) (11, 12, 13)] make the analysis of large numbers of samples quite feasible, but the Technicon Autoanalyzer is no longer commercially available, and the HPLC technique is expensive. Therefore, these methods do not optimally meet the demands of epidemiological surveys, especially in developing countries.

Here, we present a rapid urinary iodide test that is very easy to perform and does not require any technical equipment or apparatus.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The rapid urinary iodide test was provided as a kit by Merck KGaA. The kit consists of materials and reagents listed below.

Materials

Included were: disposable columns, 65 x 10.5 mm, packed with purified activated charcoal (Merck patent number WO 96/27794) for removing interfering substances; column support; three test cups (25 x 50 mm); and color scale (Fig. 1Go pictogram).



View larger version (19K):
[in this window]
[in a new window]
 
Figure 1. Pictogram, showing five color categories corresponding to three ranges of iodide concentrations. The test result of the proposed rapid urinary iodide test is obtained by comparing the color of the chemical reaction (see text) with this pictogram.

 
Reagents

Included were: buffer solution [citrate-hydrochloric acid (pH 4.0), Merck catalog no. 1.09435]; peracetic acid/H2O2 (dropping bottle), 1.2% in 30% H2O2; and 3,3',5,5'-TMB (dropping bottle), 2.5 mmol/L analytical grade in ethanol.

Apparatus

Apparatus included a spectrophotometer (Shimadzu Corp., Kyoto, Japan); and HPLC equipment (all components from Waters Chromatography Div., Millipore, Milford, MA (Ref.12).

Procedures

Collection of urine samples. For a period of 4 weeks, we collected 370 random urine samples from 370 consecutive patients who were referred to our clinic for thyroid examination. For dilution experiments, an additional 51 random urine specimens were assembled from patients within 1 week.

Performance of the rapid urinary iodide test. As discussed below, each urine sample must be tested within 2 h after collection. Further, the test cannot be performed on frozen specimens.

Dilution of the urine sample Using a pipet, 1 mL of the urine sample was placed into test cup 1, and 4 mL of the buffer solution was added.

Column preparation Columns were initially filled with a weak alcoholic solution. This solution was removed by pouring it out. Then the column was mounted to test cup 2 using the column support. First, the column was equilibrated with 3 mL of the buffer solution. After the column run dry, 2 mL of the diluted urine sample in test cup 1 was applied to the column. The column was allowed to run dry again. Then, the solution in test cup 2 was discarded.

Separation procedure (removal of interfering substances) The column was mounted to test cup 3 again using the column support. Using a pipet, 2 mL of the diluted urine sample in test cup 1 was applied to the column, and the eluate in test cup 3 was collected. The column was discarded, and the column support was removed. It is necessary to carry out the following step within 10 min after collection of the eluate to avoid deterioration of the sensitivity of the color reaction.

Iodide determination Using a pipet, 150 µL (or 6 drops) TMB was applied to the solution in test cup 3. The catalytic reaction was started by adding 25 µL (one drop) of peracetic acid/H2O2, mixing by gently shaking the cup, waiting approximately 30–60 sec, and then comparing the color of the solution with the color ranges of the pictogram (Fig. 1Go).

Spectral characteristics/colorimetry. After addition of peracetic acid/H2O2 to the solution in test cup 3, containing the eluate and TMB (see above), optical spectra were recorded after precisely 90 sec. In the visible region, two peaks appeared at 370 and 655 nm (Fig. 2Go). Because of correspondence with the visual appearance of the solution, the absorbance was measured at 655 nm, in a 1-cm path cell, against a water blank.



View larger version (18K):
[in this window]
[in a new window]
 
Figure 2. Absorbance spectrum of the iodide catalyzed oxidation of TMB. There are three maxima. Because of correspondence with the visual impression, the absorbance of each sample was measured at 655 nm.

 
Comparison method (HPLC analysis). Free inorganic iodide in the urine samples was determined using paired-ion, reversed-phase HPLC, as recently described (12).

Photometric detection. The catalytic effect of iodide in the redox reaction between the colorless 3,3',5,5'-TMB and the peracetic acid/H2O2, to yield colored products, is the basis of the photometric method used by the rapid urinary iodide test for determination of iodide in urine. The first colored product is a blue charge-transfer complex (Fig. 3Go) of the parent diamine and the diamine oxidation product (14). This species exists in rapid equilibrium with the TMB-radical cation (Fig. 3Go). Incubations with high iodide concentrations turn blue, pass through a green stage, and finally become yellow. The green solution (see pictogram, Fig. 1Go) is simply a mixture of the initial blue product and final yellow component (14).



View larger version (17K):
[in this window]
[in a new window]
 
Figure 3. Iodide catalyzed oxidation of 3,3'5,5'-TMB by peracetic acid/H2O2, yielding colored products. The blue charge-transfer complex exists in rapid equilibrium with the TMB-radical cation.

 
Dilution of urine samples. Fifty-one urine samples, collected in addition, when showing a color reaction in the test corresponding to color ranges 2 or 3 of the pictogram (Fig. 1Go), were diluted 1:1 with buffer solution (500 µL buffer and 500 µL urine). The test procedure was carried out on these diluted urines, and the results were compared with those obtained from the undiluted ones.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Distribution of the urine samples

The distribution of urinary iodide in 370 consecutive patients is given in Fig. 4Go. The median of the distribution is 91 µg/L (0.72 µmol/L). The iodide concentrations varied between 5 and 6600 µg/L (0.04–51.97 µmol/L). If patients on medical treatment for goiter or with a history of exposure to large amounts of exogenous iodine caused by radiological procedures were excluded (n = 76), the median of the resulting distribution would be 71 µg/L (0.56 µmol/L). This result is in agreement with corresponding data from other regions in Germany (15).



View larger version (20K):
[in this window]
[in a new window]
 
Figure 4. Distribution of urinary iodide in 370 consecutive patients from Wuerzburg and its surrounding area being referred for thyroid examination. The concentrations were determined by HPLC; 76 samples (>2000 µg/L) from patients with a history of exposure to large amounts of iodine caused by radiological procedures, are not shown. According to the classification, as recommended by the WHO, the population is affected by a mild degree of IDD.

 
Analytic performance

The mean (± SD) of the final column eluate, as determined by weighing 39 eluates, was 2.007 (0.044) mL. The volumes, therefore, are uniform and can be extrapolated back to the starting urine sample, because 2 mL of the diluted sample were applied to the column (see previous Separation procedure).

Interobserver reproducibility was excellent and was tested by having four observers read the color of the reaction of the first 50 samples and by having two observers for the remainder of the urine samples. Because of the clear appearance of the color, 30–60 sec after starting the reaction, no differences were found between the different observers.

Possible disturbing factors and influences

To assess the stability of columns and reagents under conditions of storage, 50 columns and two sets of reagents were stored for 10 months at room temperature (varying from 18 C in wintertime to approximately 30 C in summertime). No difference was observed, with respect to the intensity of the color reaction between tests performed with these columns and reagents and tests carried out with new kits stored at 7 C in the refrigerator.

To investigate whether environmental temperature, especially heat, can affect the results of the chemical reaction, five urine samples with iodide concentrations of 72, 95, 139, 160, and 250 µg/L (0.57, 0.75, 1.09, 1.26, and 1.97 µmol/L) were tested at room temperature (24 C) and at 43 C incubation temperature after heating urines, columns, and reagents up to this temperature for 2 h in an incubator. The tests done in the incubator and at room temperature gave the same correct results.

Possible effects of interfering substances were assessed by adding known amounts of potassium thiocyanate, L-ascorbic acid, sodium sulfide, and sodium chloride to three urine samples with 59, 169, and 287 µg iodide/L (0.46, 1.33, and 2.26 µmol/L) to a final concentration of 300 µmol/L for thiocyanate, 20 mmol/L for ascorbic acid, 50 µmol/L for sulfide, and 100 mmol/L for chloride. Correct results were obtained, and no differences were observed when testing these urines, native and spiked with the compounds above.

The test carried out on aqueous solutions of potassium iodate did not show any color reaction; the method, therefore, does not detect iodine in any other biologically relevant form than iodide.

Comparison between spectrophotometry and HPLC

For comparison, the iodide content of the 370 urine samples was determined by both spectrophotometry and HPLC. The results, in terms of absorbance vs. HPLC data, are given in Fig. 5Go. There is an almost-linear relationship up to 500 µg/L (3.94 µmol/L) iodide. At higher iodide concentrations, the absorbance shows a nonlinear increase, reaching a plateau at about 1500 µg/L (11.81 µmol/L). The r value is 0.94, calculated by nonlinear regression analysis.



View larger version (15K):
[in this window]
[in a new window]
 
Figure 5. Comparison of absorbance, measured spectrophotometrically at 655 nm with HPLC data. There is an almost-linear relationship up to 500 µg/L iodide. The data show a high correlation, but several points lie outside the 95% confidence bands.

 
Comparison between rapid urinary iodide test and HPLC

The data obtained, using the rapid urinary iodide test for determining the iodide content of the same 370 urine samples, are plotted in Fig. 6Go, with HPLC as a reference method. Corresponding to the color ranges of the pictogram (see Fig. 1Go), four panels (A-D) are shown, each representing the classification of urines, with respect to the color of the chemical reaction observed in the rapid test. As can easily be seen (Fig. 6Go, A, C, and D), there is good agreement between the rapid test and the HPLC data for urines with high (Fig. 6Go, C and D) and low (Fig. 6AGo) iodide concentrations. The deviations from the HPLC values (shaded areas in Fig. 6Go) are relatively small, amounting to approximately 8% per color range. Larger discrepancies with the HPLC data are seen only in the lower range of color scales 2+3 (Fig. 6BGo), where 17% false-positive results are found. In these cases, the rapid test shows a color reaction despite the relatively low urinary iodide concentrations between 50 and 100 µg/L (0.39–0.79 µmol/L). To solve the problem of ambiguous results in color ranges 2 or 3, dilution experiments were carried out on an additional 51 urines [median urinary iodide, 228 µg/L (1.80 µmol/L); range: 72–478 µg/L (0.57–3.76 µmol/L)]. In comparison with the iodide concentrations determined by HPLC, the results allow the following classification: if the diluted urine gives no color reaction, the iodide concentration of the undiluted urine is usually less than 200 µg/L (<1.57 µmol/L), but at most, equal to 250 µg/L (1.97 µmol/L); in the case of a color reaction despite dilution, the iodide content of the undiluted urine is usually more than 200 µg/L (>1.57 µmol/L) but not lower than 180 µg/L (1.42 µmol/L).



View larger version (60K):
[in this window]
[in a new window]
 
Figure 6. Comparison between the results obtained by the rapid urinary iodide test and the HPLC method. A-D, Results of the rapid test for each color range, as given in the pictogram (Fig. 1Go) and the corresponding iodide concentrations determined by HPLC. Deviations of the rapid test results from the HPLC values are depicted as shaded areas. For a more detailed explanation, refer to the text.

 
The classification of all samples, by number and percentage of samples in each category, is given in Table 1Go. A very good agreement among HPLC, spectrophotometry, and the rapid urinary iodide test is obtained. The same is true for the calculated median values.


View this table:
[in this window]
[in a new window]
 
Table 1. Classification of 370 urine samples by three categories: number and percentage of samples in each category, as determined by HPLC, spectrophotometry, and the rapid urinary iodide test

 
Extrapolating the median of a distribution of urinary iodine concentrations from the percentage of samples below 100 µg/L (0.79 µmol/L)

Data collected between 1993 and 1994 in a prospective nationwide survey in Germany show that it is possible to determine with sufficient precision the median of a given distribution of urinary iodine concentrations solely from the percent of samples with urinary iodine less than 100 µg/L (0.79 µmol/L). A total number of 6815 subjects, belonging to various age groups and spread over 34 regions throughout in Germany, could be enrolled in this study. Random samples of urine were collected from 6381 clinically euthyroid persons without history of thyroid disease, and the samples were measured for iodine concentration using a modification of the colorimetric method of Sandell and Kolthoff. Part of these data was published in 1996 by Hampel (16). With kind permission by the author (R. Hampel, University of Rostock, FRG) and by the sponsor of the study (Merck KGaA), we could use the original data of the whole study to establish a relationship between the median values of 37 distributions of urinary iodine concentrations encompassing 7849 subjects (3 data sets from Wuerzburg collected in 1986, 1990, and 1997, with a total number of 1468 persons, were included) and the corresponding percentages of samples below 100 µg/L (0.79 µmol/L). The correlation shown in Fig. 7Go is excellent (r = -0.99) and statistically highly significant (P < 10-6).



View larger version (23K):
[in this window]
[in a new window]
 
Figure 7. High correlation between the median values of 37 distributions of urinary iodine concentrations and the corresponding percentages of samples below 100 µg/L. The data were collected between 1993 and 1994 in a nationwide survey in Germany; 3 data sets from Wuerzburg were included, giving a total number of 7849 random urine samples. This figure can be used for extrapolating a median of distribution from the percent of samples below 100 µg/L.

 
Therefore, it is possible to calculate the median (y) of a given distribution of urinary iodine concentrations, from the percentage (x) of samples below 100 µg/L (0.79 µmol/L) using the regression equation: y = 179.78 - 1.60x (Fig. 7Go), with an SE of estimate (SEE) of only 2.6 µg/L (0.02 µmol/L).

To evaluate the precision of the test in determining the percentage of samples, we constructed (by random number assignment) 50 subgroups, each containing 50 samples from our original data set (n = 370) and calculated the corresponding percentages of samples below 100 µg/L (0.79 µmol/L), as classified by the rapid test. The mean value of the percentages of samples below 100 µg/L (0.79 µmol/L) was 51.96%, with a coefficient of variation (CV) of 11.7%.


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Suitability of the rapid urinary iodide test for the assessment of iodine deficiency in epidemiological surveys

Bourdoux (17) has shown that information about the iodine status of a population can easily be obtained from a set of 50–100 casual urine samples. Because of the important scatter of urinary iodide concentrations yielding skewed distributions, Bourdoux (18) proposed a classification (Table 2Go) of iodine status, based on his experience with thousands of samples from several countries throughout the world, using an arbitrary categorization of urinary iodide concentrations: <=20, <=50, and <=100 µg/L (<=0.16, <=0.39, <=0.79 µmol/L). These three ranges are related to 3 levels of iodine deficiency (mild, moderate, and severe) suggested by international organizations (2, 7, 19, 20), who have adopted a simplified classification based only on single median values (2, 7). Table 2Go suggests that these median values may be correlated with the percentage of samples below 100 µg/L (0.79 µmol/L). We could indeed derive from 37 distributions a corresponding relationship showing a high correlation (r = -0.99). Therefore, it is possible to extrapolate the median of a given distribution from the percentage of samples below 100 µg/L (0.79 µmol/L) by using Fig. 7Go. As can easily be seen, the correlation shown in Fig. 7Go is in very close agreement with Bourdoux’s classification (Table 2Go). If, for example, 50–80% of all samples are below 100 µg/L (0.79 µmol/L), the corresponding median is between 50 and 100 µg/L (0.39–0.79 µmol/L), and the iodine intake is mildly deficient; if more than 80% of all samples are below 100 µg/L, the median lies below 50 µg/L (0.39 µmol/L), and the iodine intake is to be classified as moderately deficient. Evaluating the precision of the rapid test at the cut-off level of 100 µg/L (0.79 µmol/L), yields a CV of 11.7%. For comparison, the mean CV of method A in Ref. 6 is 11.0%.


View this table:
[in this window]
[in a new window]
 
Table 2. Classification of iodine intake according to the distribution of urinary iodide concentrations, suggested by Bourdoux (18) and according to median values recommended by the WHO-UNICEF-ICCIDD consultation (7,20)

 
The other results obtained in the present study are summarized in Table 1Go. The data show a very good agreement among HPLC, spectrophotometry, and rapid test results, with respect to the classification of all samples by number and percentage of samples in each category. In more than 50% of all samples, iodide concentrations <= 100 µg/L (0.79 µmol/L) were found by HPLC, spectrophotometry, and the rapid test. This is equivalent to a mildly deficient iodine intake, according to Table 2Go, and corresponds to the median of 91 µg/L (0.72 µmol/L) of the whole distribution. The median values calculated by using the regression equation of Fig. 7Go also are given in Table 1Go; they are in good agreement with the exact value. Furthermore, because of the correct classification of samples also in the ranges between 100–300 µg/L (0.79–2.36 µmol/L) and more than 300 µg/L (>2.36 µmol/L), this test allows the rapid identification of the percentage of subjects who, in case of supplementation, move from one category to another.

Compared with other simple methods (6, 21, 22), the rapid test is extremely easy to perform and does not require any instrumentation or apparatus. Only columns with purified activated charcoal are needed. One technician can analyze, in parallel, 8–10 samples; the total analysis time for one sample is 15 min. About 60–80 samples can be tested this way within 2 h, at a cost of 0.5–1.0 $(US) per sample (depending on the number of kits ordered), labor not included. This rapid test allows on-site monitoring of iodine deficiency under conditions of heat and storage usually found in developing countries, and it makes shipping of samples unnecessary. For that reason, the test is well suited to epidemiological investigations, especially in these countries.

Suitability of the rapid urinary iodide test for estimating the iodine intake of a single individual

Fig. 6Go shows that an unambiguous interpretation of a single test result is possible if the color of the chemical reaction can be related to ranges 4 or 5, meaning that this sample is suspected to be iodine contaminated, or if no color reaction occurs (~ color range 1). In the latter case, iodine contamination can be excluded because the iodide concentration is below 100 µg/L (0.79 µmol/L) in more than 90% of the samples, and it does not exceed 200 µg/L (1.57 µmol/L) (Fig. 6AGo). An equivocal result is obtained (Fig. 6BGo) if the color of the reaction corresponds to ranges 2 or 3 ~ 100–300 µg/L (0.79–2.36 µmol/L), where 17% of the urine samples of this category gave a color reaction despite the fact that the iodide concentrations were below 100 µg/L (0.79 µmol/L), as measured by HPLC. Interfering substances and matrix effects are very likely to cause this ambiguity. One of the interfering compounds is possibly ammonium, which originates from the decomposition of urea in long-standing urines. During freezing and thawing, the same process may be responsible for the formation of interfering products. By adding ammonium to urine samples, for example, the color reaction can be completely suppressed. Such compounds are only partially removed by the activated carbon. So, if the concentration of interfering substances in a urine sample is relatively high, color reaction may not occur, even when the iodide concentration is above 100 µg/L (0.79 µmol/L). If, on the contrary, the amount of interfering substances is relatively low, a color reaction may be observed despite iodide concentrations below 100 µg/L (0.79 µmol/L), because the color reaction itself is sensitive also to small iodide concentrations (as observed when giving the reagents to pure iodide calibrators diluted only with buffer). In the special matrix of urines, however, the cut-off level is 100 µg/L (0.79 µmol/L). The problem of ambiguous results in color ranges 2 or 3 can be solved by repeating the test with the same urine diluted 1:1 with buffer. The test result obtained from the diluted urine allows a final statement, with respect to the iodide content of the undiluted sample. A second determination from a dilution, however, is required only if the iodine intake of a single individual is to be estimated, especially if iodine contamination should be excluded. In field studies, on the other hand, it is not necessary to dilute any sample, because the test yields the correct percentages of samples in each range (Table 1Go).

In conclusion, comparison with the HPLC method clearly demonstrates that this rapid test for determination of urinary iodide is well suited to the assessment of iodine deficiency and to the monitoring of iodine supplementation in epidemiological surveys. With respect to the determination of iodide in a single urine sample, the test allows the detection or exclusion of iodine contamination (excess iodide), which is important in iodide-induced hyperthyroidism (23).

Received March 13, 1997.

Revised August 27, 1997.

Revised November 7, 1997.

Accepted November 20, 1997.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Dunn JT. 1992 Iodine deficiency - the next target for elimination? N Engl J Med. 326:267–268 (editorial).[Medline]
  2. Hetzel BS, Dunn JT. 1989 The iodine deficiency disorders: their nature and prevention. Annu Rev Nutr. 9:21–38.[CrossRef][Medline]
  3. World Health Organization. 1994 Forty-Seventh World Health Assembly, Geneva, 2–12 May 1994. Resolutions and decisions; annexes. Geneva, World Health Organization 47 (unpublished document WHA47/1994/REC/1).
  4. World Health Organization. 1996 Trace elements in human nutrition, and health. Geneva, p 58.
  5. Tonglet R, Bourdoux P, Minga T, Ermans AM. 1992 Efficacy of iodized oil in the control of iodine deficiency in Zaire. N Engl J Med. 326:236–241.[Abstract]
  6. Dunn JT, Crutchfield HE, Gutekunst R, Dunn AD. 1993 Two simple methods for measuring iodine in urine. Thyroid. 3:119–123.[Medline]
  7. Delange F. 1994 Iodine deficiency in Europe. In: Hennemann G, Krenning E, eds. Thyroid International Darmstadt: Germany; (Merck). 3:3–20.
  8. Bourdoux P, Delange F, Filetti S, Thilly C, Ermans AM. 1985 Reliability of the iodine/creatinine ratio: a myth? In: Hall R, Köbberling J, eds. Thyroid Disorders Associated with Iodine Deficiency and Excess. Serono Symposia. Vol. 22. New York: Raven Press; 145–152.
  9. Gochmann N. 1964 Eine vollautomatische Bestimmung des proteingebundenen Jods im Serum. In: Automation in der analytischen Chemie, Technicon Symposium Frankfurt: Bad Vilbel: Germany; Technicon, p 429.
  10. Garry PJ, Lashley DW, Owen GM. 1973 Automated measurement of urinary iodine. Clin Chem. 19:950–953.[Abstract]
  11. Odink J, Bogaards JJP, Sandman H. 1988 Excretion of iodide in 24-h urine as determined by ion-pair reversed-phase liquid chromatography with electrochemical detection. J Chromatogr. 431:309–316.[Medline]
  12. Rendl J, Seybold S, Börner W. 1994 Urinary iodide determined by paired-ion reversed-phase HPLC with electrochemical detection. Clin Chem. 40:908–913.[Abstract/Free Full Text]
  13. Mura P, Papet Y, Sandez A, Pirion A. 1995 Rapid and specific high-performance liquid chromatographic method for the determination of iodide in urine. J Chromatogr B Biomed Appl. 664:440–443.[CrossRef][Medline]
  14. Josephy PD, Eling T, Mason RP. 1982 The horseradish peroxidase-catalyzed oxidation of 3,5,3',5'-tetramethylbenzidine. J Biol Chem. 7:3669–3675.
  15. Gutekunst R, Magiera U, Teichert HM. 1993 Jodmangel in der Bundesrepublik Deutschland. Med Klin. 88:525–528.[Medline]
  16. Hampel R, Kuhlberg T, Zollner H, et al. 1996: Aktueller Stand der alimentären Iodversorgung in Deutschland. Z Ernährungswiss. 35:2–5.
  17. Bourdoux P. 1988 Measurement of iodine in the assessment of iodine deficiency. IDD Newsletter. 4:8–12.
  18. Bourdoux P. 1993 Biochemical evaluation of iodine status. In: Delange F, Dunn JT, Glinoer D, eds. Iodine Deficiency in Europe: a Continuing Concern. New York: Plenum Press; 119–125.
  19. Dunn JT, van der Haar F. 1990 A Practical Guide to the Correction of Iodine Deficiency. International Council for the Control of Iodine Deficiency Disorders. The Netherlands.
  20. Delange F. 1996 Iodine deficiency disorders and their prevention: a worldwide problem. In: Braverman LE, Koehrle J, Eber O, Langsteger W, eds. Thyroid and Trace Elements. 6th Thyroid Symposium. Vienna: Berlin Blackwell Wissenschaftsverlag; p 93–103 (CD-ROM).
  21. Wawschinek O, Eber O, Petek W, Wakonig P, Gürakar A. 1985 Bestimmung der Harnjodausscheidung mittels einer modifizierten Cer-Arsenitmethode. Ber ÖGKC (Österr Ges Klin Chem). 8:13–15.
  22. Pino S, Fang SL, Braverman LE. 1996 Ammonium persulfate: a safe alternative oxidizing reagent for measuring urinary iodine. Clin Chem. 42:239–243.[Abstract/Free Full Text]
  23. Roti E, Vagenakis AG. 1991 Effect of excess iodide: clinical aspects. In: Braverman LE, Utiger RD, eds. Werner and Ingbar’s The Thyroid. A Fundamental and Clinical Text. 6th ed. Philadelphia: Lippincott; 390–402.



This article has been cited by other articles:


Home page
Clin. Chem.Home page
D. Gnat, A. D. Dunn, S. Chaker, F. Delange, F. Vertongen, and J. T. Dunn
Fast Colorimetric Method for Measuring Urinary Iodine
Clin. Chem., January 1, 2003; 49(1): 186 - 188.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Als, A. Helbling, K. Peter, M. Haldimann, B. Zimmerli, and H. Gerber
Urinary Iodine Concentration follows a Circadian Rhythm: A Study with 3023 Spot Urine Samples in Adults and Children
J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1367 - 1369.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Remer and A. Neubert
A Never-Ending Story of an Insufficient Iodine Status Without Mandatory Iodization of Foods?--A German Experiencec
J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3755a - 3756.
[Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rendl, J.
Right arrow Articles by Reiners, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rendl, J.
Right arrow Articles by Reiners, C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals